GLP-1 medications are better for post-meal glucose spikes and weight loss, while insulin is better for overall blood sugar control in severe cases
En estudios clnicos, los pacientes tratados con tirzepatida han perdido entre un 15% y 20% de su peso corporal despus de varios meses de tratamiento, una cifra mayor en comparacin con otros tratamientos
Your injection is administered by a qualified clinical team member at every visit
10.1111/trf.16395 50 SalmeenA.BarfordD
2018 Feb 1;22(2):177-190.e7
arthralgia incidence in trials is generally similar to placebo Rapid weight loss from GLP-1 treatment may alter biomechanical loading on joints, causing temporary adjustment-related discomfort Patients prescribed GLP-1 medications often have type 2 diabetes or obesity, conditions independently associated with increased osteoarthritis rates Seek medical advice for severe, worsening, or persistent joint pain, or if accompanied by swelling, redness, warmth, or systemic symptoms Report suspected medication side effects through the MHRA Yellow Card scheme to support ongoing safety monitoring Table of Contents Understanding GLP-1 Medications and Their Common Side Effects GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), most commonly cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea
